Acceleron Pharma Inc (NASDAQ:XLRN) Director Richard F. Pops sold 37,500 shares of the stock in a transaction dated Tuesday, March 6th. The stock was sold at an average price of $41.42, for a total value of $1,553,250.00. Following the completion of the sale, the director now directly owns 68,750 shares of the company’s stock, valued at $2,847,625. The sale was disclosed in a filing with the SEC, which is available at this link.
XLRN stock traded down $0.45 during midday trading on Friday, reaching $43.70. The company had a trading volume of 355,045 shares, compared to its average volume of 285,218. Acceleron Pharma Inc has a 1-year low of $24.37 and a 1-year high of $46.93. The firm has a market capitalization of $1,984.81, a P/E ratio of -16.19 and a beta of 1.39.
Acceleron Pharma (NASDAQ:XLRN) last posted its quarterly earnings results on Tuesday, February 27th. The biopharmaceutical company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.02). Acceleron Pharma had a negative return on equity of 38.71% and a negative net margin of 804.49%. The company had revenue of $3.71 million during the quarter, compared to the consensus estimate of $3.39 million. research analysts forecast that Acceleron Pharma Inc will post -2.5 EPS for the current year.
A number of institutional investors have recently added to or reduced their stakes in XLRN. Xact Kapitalforvaltning AB purchased a new position in shares of Acceleron Pharma during the 4th quarter valued at $217,000. MetLife Investment Advisors LLC bought a new stake in Acceleron Pharma in the fourth quarter worth $739,000. TIAA CREF Investment Management LLC lifted its stake in Acceleron Pharma by 3.8% in the fourth quarter. TIAA CREF Investment Management LLC now owns 87,027 shares of the biopharmaceutical company’s stock worth $3,693,000 after purchasing an additional 3,178 shares during the last quarter. Teachers Advisors LLC lifted its stake in Acceleron Pharma by 36.7% in the fourth quarter. Teachers Advisors LLC now owns 80,066 shares of the biopharmaceutical company’s stock worth $3,398,000 after purchasing an additional 21,508 shares during the last quarter. Finally, California State Teachers Retirement System lifted its stake in Acceleron Pharma by 14.5% in the fourth quarter. California State Teachers Retirement System now owns 59,177 shares of the biopharmaceutical company’s stock worth $2,511,000 after purchasing an additional 7,499 shares during the last quarter. Institutional investors and hedge funds own 88.21% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Acceleron Pharma Inc (NASDAQ:XLRN) Director Richard F. Pops Sells 37,500 Shares” was originally posted by BBNS and is the property of of BBNS. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://baseballnewssource.com/2018/03/18/insider-selling-acceleron-pharma-inc-xlrn-director-sells-37500-shares-of-stock/2006592.html.
Acceleron Pharma Company Profile
Acceleron Pharma Inc is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its research focuses on key natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta (TGF-beta), protein superfamily.
Receive News & Ratings for Acceleron Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acceleron Pharma and related companies with MarketBeat.com's FREE daily email newsletter.